← Leaderboards
Hong Wu
University Of California Los Angeles
$8,515,329
Attributed
$10,475,122
Total exposure
9
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$10,475,122 · 9
By mechanism
R01$3,434,696 · 2
U01$2,939,689 · 1
P50$2,699,718 · 4
P30$1,008,283 · 1
T32$392,736 · 1
Top collaborators
- Peter S Nelson5 shared
- Owen N Witte5 shared
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Ira Kurtz$12,453,596
- Harold H Koeffler$10,694,831
- Shahriar Yaghoubi$1,141,071
- William M Pardridge$11,519,163
- Ruben J. Boado$14,771,226
Others in their field
Top investigators on “Molecular”
- David Heimbrook · Leidos Biomedical Research, Inc.$871,088,761
- Leonard Freedman · Leidos Biomedical Research, Inc.$468,573,385
- Richard Webby · St. Jude Children'S Research Hospital$254,843,170
- Larry Arthur$238,531,074
- Gregory H Reaman · National Childhood Cancer Foundation$230,630,913
- Ralph Parchment · Leidos Biomedical Research, Inc.$193,231,914
Research focus
MolecularTumorBaseMouse ModelMalignant Neoplasm Of ProstatePten GeneGrowthAndrogensProstatePathway InteractionsMutationDesignMalignant NeoplasmsEventStemInhibitor/AntagonistMonitorResponseSignal PathwayTumorigenesisOncogenicMolecular GeneticsResistanceCells
Grant awards (51)
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$182,079
P50 · FY2018 · CA · contact PI
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$263,817
P50 · FY2017 · CA · contact PI
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$247,450
P50 · FY2016 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$593,215
U01 · FY2015 · CA
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$251,930
P50 · FY2015 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$579,004
U01 · FY2014 · CA · contact PI
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$247,310
P50 · FY2014 · CA · contact PI
Molecular Imaging directed Diagnosis and Interrogation of Human Soft Tissue....$217,123
P50 · FY2014 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$544,406
U01 · FY2013 · CA · contact PI
PI3K/AKT and MAPK Pathway Inhibition Therapies in Metastatic and Castration Resi$245,346
P50 · FY2013 · CA · contact PI
Molecular Imaging directed Diagnosis and Interrogation of Human Soft Tissue....$204,029
P50 · FY2013 · CA · contact PI
Embryonic Stem Cell/ Transgenic Mice Shared Resource$188,613
P30 · FY2013 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$600,277
U01 · FY2012 · CA · contact PI
Tumor Cell Biology Training Program$392,736
T32 · FY2012 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$306,210
R01 · FY2012 · CA · contact PI
Embryonic Stem Cell/ Transgenic Mice Shared Resource$190,534
P30 · FY2012 · CA · contact PI
Molecular Imaging directed Diagnosis and Interrogation of Human Soft Tissue....$115,752
P50 · FY2012 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$20,610
R01 · FY2012 · CA · contact PI
Influences of the Microenvironment on Cancer Stem Cells$622,787
U01 · FY2011 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$306,210
R01 · FY2011 · CA · contact PI
Embryonic Stem Cell/ Transgenic Mice Shared Resource$183,828
P30 · FY2011 · CA · contact PI
Molecular Imaging directed Diagnosis and Interrogation of Human Soft Tissue....$121,808
P50 · FY2011 · CA · contact PI
Animal Models Core$87,349
P50 · FY2011 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$57,979
R01 · FY2011 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$315,680
R01 · FY2010 · CA · contact PI
Embryonic Stem Cell/ Transgenic Mice Shared Resource$228,670
P30 · FY2010 · CA · contact PI
Molecular Imaging directed Diagnosis and Interrogation of Human Soft Tissue....$154,381
P50 · FY2010 · CA · contact PI
Animal Models Core$91,946
P50 · FY2010 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$59,951
R01 · FY2010 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$315,680
R01 · FY2009 · CA · contact PI
Embryonic Stem Cell/ Transgenic Mice Shared Resource$216,638
P30 · FY2009 · CA · contact PI
Animal Models Core$91,919
P50 · FY2009 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$37,942
R01 · FY2009 · CA · contact PI
Study of cell-of-origin and cancer stem cells in prostatic adenocarcinoma$315,680
R01 · FY2008 · CA · contact PI
PTEN and Prostate Cancer Progression$297,832
R01 · FY2008 · CA · contact PI
Animal Models Core$91,916
P50 · FY2008 · CA · contact PI
PTEN and Prostate Cancer Progression$44,919
R01 · FY2008 · CA · contact PI
PTEN and Prostate Cancer Progression$297,832
R01 · FY2007 · CA · contact PI
Animal Models Core$85,563
P50 · FY2007 · CA · contact PI
PTEN and Prostate Cancer Progression$42,520
R01 · FY2007 · CA · contact PI
PTEN and Prostate Cancer Progression$306,727
R01 · FY2006 · CA · contact PI
PTEN and Prostate Cancer Progression$42,693
R01 · FY2006 · CA · contact PI
PTEN and Prostate Cancer Progression$294,635
R01 · FY2005 · CA
PTEN and Prostate Cancer Progression$41,574
R01 · FY2005 · CA
PTEN and Prostate Cancer Progression$292,756
R01 · FY2004 · CA
PTEN and Prostate Cancer Progression$37,266
R01 · FY2004 · CA
Imaging tumor progression &metastasis caused by deletion of PTEN$0
P50 · FY2002 · CA
Core--Mouse Models$0
P50 · FY2002 · CA
Imaging tumor progression &metastasis caused by deletion of PTEN$0
P50 · FY2002 · CA
Imaging tumor progression &metastasis caused by deletion of PTEN$0
P50 · FY2001 · CA
Imaging tumor progression &metastasis caused by deletion of PTEN$0
P50 · FY2000 · CA